PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact

Prostate Cancer Therapeutics Market .pdf

Original filename: Prostate Cancer Therapeutics Market.pdf

This PDF 1.4 document has been generated by Online2PDF.com, and has been sent on pdf-archive.com on 02/05/2018 at 12:53, from IP address 116.75.x.x. The current document download page has been viewed 261 times.
File size: 217 KB (6 pages).
Privacy: public file

Download original PDF file

Document preview

Prostate Cancer Therapeutics Market - Global Industry Analysis, Size,
Share, Trends and Forecast, Up to 2023
Infinium Global Research

A latest report has been added to the wide database of Prostate Cancer Therapeutics Market by Infinium Global Research.
This report studies the Prostate Cancer Therapeutics Market by Component (Hormonal therapy (LHRH antagonists, LHRH
agonists and Anti-androgen), (Chemotherapy, Immunotherapy, Radiation therapy) market status and outlook of global and
major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different
segments & countries in recent years and to forecast the values for the next six years. Prostate Cancer Therapeutics Market
provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape,
latest trends, and product offerings of the major companies in the Prostate Cancer Therapeutics Market. According to the
report the Global Prostate Cancer Therapeutics Market is projected to grow at a CAGR of around 9.9% in terms of value over
the period of 2017-2023. Innovations in the development of new drugs and therapies, large number of new drugs entering
into the market with FDA approval, high growth in hormone-refractory prostate cancer therapeutics market, and rise in base
of aging population are the key driving factors for the growth of this market. In addition, rise in prevalence of prostate cancer,
changing lifestyle habits of populations, increased patient’s healthcare awareness, and increasing demand for non-invasive
therapies are further expected to propel the market growth in the coming years. Along with these driving factors, the market
for prostate cancer is facing some challenges such as time consuming regulatory compliance and high cost of prostate drugs.
However, the market for prostate cancer is likely to rise in the future due to the large number of ongoing innovations for the
treatment of prostate cancer.
Geographically, North America is the leading contributor to the market and is expected to retain its position during the
forecast period due to high awareness, large base of prostate cancer patients, rise in investments, and various initiatives by
government in the healthcare sector. However, Asia-Pacific market is expected to grow at a faster rate during the forecast
period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments
and growing awareness among the population about the treatment options available in the market.
Companies profiled:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma Inc.
Bristol-Myers Squibb
Johnson & Johnson
Pfizer Inc.
Infinium Global Research

AbbVie, Inc.
Teva Pharmaceuticals
Takeda Pharmaceuticals, etc.
Make an Enquiry
Report Highlights:
The report delivers a strategic analysis of the global market for prostate cancer therapeutics and growth forecast for the
period from 2017 – 2023. The scope of the report includes competitive analysis of various market players who are operating in
the market, segmental analysis based on type. It also covers geographical analysis of the market with growth forecast for the
period of 2017 – 2023. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into
market dynamics and industry competition.
Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business
opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of
leading players, recent developments in the industry and various business strategies adopted by them. This report will help
players in global prostate cancer therapeutics market to plan and implement their strategies in different market areas such as
emerging geographies, and new technologies.
Get a Sample Request
Table of Contents:1. Scope of the report
1.1 Report description
1.2 Research methodology
1.3 List of abbreviations
Infinium Global Research

1.4 Market segmentation
2 Executive Summaries
3 Prostate Cancer Overview
4 Qualitative Analysis
4.1 Market overview
4.1.1 Drivers
4.1.2 Restraints
4.2 Porters five forces analysis
4.3 Competitive matrix of the key companies
5 Global Prostate Cancer Therapeutics Market, by Component, 2017 - 2023
5.1 Hormonal therapy
5.1.1 LHRH (Luteinizing Hormone Releasing Hormone) antagonists
5.1.2 LHRH (Luteinizing Hormone Releasing Hormone) agonists
5.1.3 Anti-androgen
5.2 Chemotherapy
5.3 Immunotherapy
Infinium Global Research

5.4 Radiation therapy
6 Global Prostate Cancer Therapeutics Market, by Geography, 2017 - 2023
6.1 North America
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.2.6 Others
6.3 APAC
6.3.1 China
6.3.2 India
6.3.3 Japan
6.3.4 Others
6.4 Rest of the World
Infinium Global Research

7 Company Profiles
7.1 Abbott Laboratories
7.2 AstraZeneca plc
7.3 Astellas Pharma Inc.
7.4 Bristol-Myers Squibb
7.5 Johnson & Johnson
7.6 Pfizer Inc.
7.7 Sanofi
7.8 AbbVie, Inc.
7.9 Teva Pharmaceuticals
7.10 Takeda Pharmaceuticals
Click the Below Full Report Link

Infinium Global Research

Related documents

prostate cancer therapeutics market
cancer therapeutics and supportive care drugs market
biosimilar market
blood cancer drugs market
premature ejaculation treatment market
biological drugs market

Related keywords